Find a Study

ALLFTD is a multisite observational research study aimed at understanding how frontotemporal lobar degeneration (FTD or FTLD) syndromes affect the brain.

An oral medication, CT1812, is being investigated for the potential treatment of Dementia with Lewy Bodies (DLB). The purpose of this clinical trial is to learn about the safety of CT1812 and how well your body tolerates a once-a-day dose of CT1812.

DLBC is an observational research study aimed at learning more about Dementia with Lewy Bodies. The trial focuses on identifying biomarkers associated with the disease.

The Memory & Aging Study by the Duke-UNC Alzheimer’s Disease Research Center aims to pinpoint the biological factors related to both regular brain aging and diseased brain decline.

The Registry is designed to increase awareness of Alzheimer’s disease and related dementias and to connect North Carolinians of all ages to research opportunities designed to improve brain health.

If you’re aged 65 and older, please volunteer for the PACT (Preventing Alzheimer’s with Cognitive Training) research study to see if computerized training exercises can reduce the risk of dementia.

This study is for people diagnosed with mild cognitive impairment. It tests the content and usability of the VRFACT, a performance-based measure of functional capacity.

APOE4 is a gene variant that some people carry that increases their risk of developing Alzheimer’s Disease later in life. Dr. Miles Berger and a team of colleagues at Duke Anesthesiology are trying to understand what effect this gene has early in life before any symptoms of Alzheimer’s Disease.